“…the Als3 adhesin, formulated with alum as adjuvant, and a dominant member of the aspartyl proteinase enzyme family, the Sap2, in a virosomal formulation. 39,75 Both vaccines show solid evidence of protection in rat and mouse models of vaginal infection by C. albicans although with a likely different mechanism of immunological protection. 30,74 Other anti-Candida vaccines, from attenuated strains of C. albicans 76 to a number of glycoconjugate of cell wall polysaccharides, 77 have also been shown to be immunogenic and protective in experimental animal models, although these, to my knowledge, have not yet been entered into clinical trials in humans.…”